Discussion
The CANVAS trial has successfully recruited 4,330
individuals with T2DM to address the initial objectives
of the study. The characteristics of the participants
enrolled are mostly representative of a high-risk diabetic
population, both in terms of the nature of the complications
reported and the types of treatments they are
receiving. The proportion of participants with a history of
atherosclerotic vascular disease is higher than is typically